Report Detail
Global (United States, European Union and China) IBS-C Drug Market Research Report 2019-2025
- RnM3702111 |
- 27 August, 2019 |
- Global |
- 124 Pages |
- QYResearch |
- Pharma & Healthcare
IBS‑C is defined as belly pain (abdominal pain) associated with constipation. The symptoms of IBS‑C are defined as long-lasting and keep coming back. Those suffering from IBS‑C also have hard or lumpy stools at least 25% of the time, and loose or watery stools less than 25% of the time.
The important driver increasing growth in the Global Irritable Bowel Syndrome with Constipation drugs Market are modern dietary habits that are having adverse effects on the human body. Some of the dietary habits leading to constipation include high intake of foods like insoluble fiber, grains, milk, fried foods, etc. Excessive intake of caffeine and alcohol increases excretion, and this loss of water through urination can also lead to IBS.
In 2019, the market size of IBS-C Drug is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for IBS-C Drug.
This report studies the global market size of IBS-C Drug, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the IBS-C Drug sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Catalent Pharmaceuticals Solutions
Nestle
Abbott Laboratories
Synergy Pharmaceuticals
Sucampo Pharmaceuticals
Novartis Pharma
Astellas Pharmaceuticals
Ardelyx
Synthetic Biologics
Teva Pharmaceutical Industries
Bama-Geve
Ferring BV
Ironwood Pharmaceuticals
Salix Pharmaceuticals
Norgine
Prometheus Laboratories
Actavis Nordic
Albireo Pharma
Yuhan Corp
Astrazeneca
The Menarini Group
Ono Pharmaceutical
Market Segment by Product Type
Linaclotide
Lubiprostone
Osmotic Laxatives
Stimulant Laxatives
Other
Market Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the IBS-C Drug status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key IBS-C Drug manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of IBS-C Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global IBS-C Drug Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Linaclotide
- 1.3.3 Lubiprostone
- 1.3.4 Osmotic Laxatives
- 1.3.5 Stimulant Laxatives
- 1.3.6 Other
- 1.4 Market Segment by Application
- 1.4.1 Global IBS-C Drug Market Share by Application (2019-2025)
- 1.4.2 Hospital Pharmacies
- 1.4.3 Retail Pharmacies
- 1.4.4 Online Pharmacies
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global IBS-C Drug Market Size
- 2.1.1 Global IBS-C Drug Revenue 2014-2025
- 2.1.2 Global IBS-C Drug Sales 2014-2025
- 2.2 IBS-C Drug Growth Rate by Regions
- 2.2.1 Global IBS-C Drug Sales by Regions 2014-2019
- 2.2.2 Global IBS-C Drug Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 IBS-C Drug Sales by Manufacturers
- 3.1.1 IBS-C Drug Sales by Manufacturers 2014-2019
- 3.1.2 IBS-C Drug Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 IBS-C Drug Revenue by Manufacturers (2014-2019)
- 3.2.2 IBS-C Drug Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global IBS-C Drug Market Concentration Ratio (CR5 and HHI)
- 3.3 IBS-C Drug Price by Manufacturers
- 3.4 Key Manufacturers IBS-C Drug Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into IBS-C Drug Market
- 3.6 Key Manufacturers IBS-C Drug Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Linaclotide Sales and Revenue (2014-2019)
- 4.1.2 Lubiprostone Sales and Revenue (2014-2019)
- 4.1.3 Osmotic Laxatives Sales and Revenue (2014-2019)
- 4.1.4 Stimulant Laxatives Sales and Revenue (2014-2019)
- 4.1.5 Other Sales and Revenue (2014-2019)
- 4.2 Global IBS-C Drug Sales Market Share by Type
- 4.3 Global IBS-C Drug Revenue Market Share by Type
- 4.4 IBS-C Drug Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global IBS-C Drug Sales by Application
6 United States
- 6.1 United States IBS-C Drug Breakdown Data by Company
- 6.2 United States IBS-C Drug Breakdown Data by Type
- 6.3 United States IBS-C Drug Breakdown Data by Application
7 European Union
- 7.1 European Union IBS-C Drug Breakdown Data by Company
- 7.2 European Union IBS-C Drug Breakdown Data by Type
- 7.3 European Union IBS-C Drug Breakdown Data by Application
8 China
- 8.1 China IBS-C Drug Breakdown Data by Company
- 8.2 China IBS-C Drug Breakdown Data by Type
- 8.3 China IBS-C Drug Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World IBS-C Drug Breakdown Data by Company
- 9.2 Rest of World IBS-C Drug Breakdown Data by Type
- 9.3 Rest of World IBS-C Drug Breakdown Data by Application
- 9.4 Rest of World IBS-C Drug Breakdown Data by Countries
- 9.4.1 Rest of World IBS-C Drug Sales by Countries
- 9.4.2 Rest of World IBS-C Drug Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Catalent Pharmaceuticals Solutions
- 10.1.1 Catalent Pharmaceuticals Solutions Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of IBS-C Drug
- 10.1.4 IBS-C Drug Product Introduction
- 10.1.5 Catalent Pharmaceuticals Solutions Recent Development
- 10.2 Nestle
- 10.2.1 Nestle Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of IBS-C Drug
- 10.2.4 IBS-C Drug Product Introduction
- 10.2.5 Nestle Recent Development
- 10.3 Abbott Laboratories
- 10.3.1 Abbott Laboratories Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of IBS-C Drug
- 10.3.4 IBS-C Drug Product Introduction
- 10.3.5 Abbott Laboratories Recent Development
- 10.4 Synergy Pharmaceuticals
- 10.4.1 Synergy Pharmaceuticals Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of IBS-C Drug
- 10.4.4 IBS-C Drug Product Introduction
- 10.4.5 Synergy Pharmaceuticals Recent Development
- 10.5 Sucampo Pharmaceuticals
- 10.5.1 Sucampo Pharmaceuticals Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of IBS-C Drug
- 10.5.4 IBS-C Drug Product Introduction
- 10.5.5 Sucampo Pharmaceuticals Recent Development
- 10.6 Novartis Pharma
- 10.6.1 Novartis Pharma Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of IBS-C Drug
- 10.6.4 IBS-C Drug Product Introduction
- 10.6.5 Novartis Pharma Recent Development
- 10.7 Astellas Pharmaceuticals
- 10.7.1 Astellas Pharmaceuticals Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of IBS-C Drug
- 10.7.4 IBS-C Drug Product Introduction
- 10.7.5 Astellas Pharmaceuticals Recent Development
- 10.8 Ardelyx
- 10.8.1 Ardelyx Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of IBS-C Drug
- 10.8.4 IBS-C Drug Product Introduction
- 10.8.5 Ardelyx Recent Development
- 10.9 Synthetic Biologics
- 10.9.1 Synthetic Biologics Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of IBS-C Drug
- 10.9.4 IBS-C Drug Product Introduction
- 10.9.5 Synthetic Biologics Recent Development
- 10.10 Teva Pharmaceutical Industries
- 10.10.1 Teva Pharmaceutical Industries Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of IBS-C Drug
- 10.10.4 IBS-C Drug Product Introduction
- 10.10.5 Teva Pharmaceutical Industries Recent Development
- 10.11 Bama-Geve
- 10.12 Ferring BV
- 10.13 Ironwood Pharmaceuticals
- 10.14 Salix Pharmaceuticals
- 10.15 Norgine
- 10.16 Prometheus Laboratories
- 10.17 Actavis Nordic
- 10.18 Albireo Pharma
- 10.19 Yuhan Corp
- 10.20 Astrazeneca
- 10.21 The Menarini Group
- 10.22 Ono Pharmaceutical
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 IBS-C Drug Sales Channels
- 11.2.2 IBS-C Drug Distributors
- 11.3 IBS-C Drug Customers
12 Market Forecast
- 12.1 Global IBS-C Drug Sales and Revenue Forecast 2019-2025
- 12.2 Global IBS-C Drug Sales Forecast by Type
- 12.3 Global IBS-C Drug Sales Forecast by Application
- 12.4 IBS-C Drug Forecast by Regions
- 12.4.1 Global IBS-C Drug Sales Forecast by Regions 2019-2025
- 12.4.2 Global IBS-C Drug Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on IBS-C Drug. Industry analysis & Market Report on IBS-C Drug is a syndicated market report, published as Global (United States, European Union and China) IBS-C Drug Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of IBS-C Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
